CPD-002, a novel VEGFR2 inhibitor, relieves rheumatoid arthritis by reducing angiogenesis through the suppression of the VEGFR2/PI3K/AKT signaling pathway
| Autor: | Jiang, Fei, Wang, Meng-qing, Zhang, Man-yu, Gu, Sheng-long, Xie, Ya-wen, Huang, Yan, Zhou, Meng-yuan, Li, Fei-long, Yang, Yu-chen, Zhang, Pei-pei, Liu, Xue-song, Li, Rong |
|---|---|
| Zdroj: | In International Immunopharmacology 20 April 2024 131 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect